Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLC

Clinical trial NCT07748325 · RECRUITING

Trial details

NCT number: NCT07748325
Sponsor: Sichuan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Adjuvant Therapy Immune Checkpoint Inhibitors

Start date: 2025-01-10
Primary completion: 2027-12-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.